Science Explorer Back to mapMap
Institution · Public Health Wales

Most cited papers from Public Health Wales

What are the most cited papers from Public Health Wales?

The most cited paper from Public Health Wales is "The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis" (Karen E Hughes, Mark A Bellis, Katherine A. Hardcastle et al., 2017), with 5,313 citations. Next come "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK" (5,030) and "Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium" (2,973).

Showing 50 of 60 papers. Every paper with more than 264 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis Karen E Hughes, Mark A Bellis, Katherine A. Hardcastle et al. · The Lancet Public Health ReviewOpen access 31 Jul 2017 5,313
2 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey et al. · The Lancet Open access765 authors 8 Dec 2020 5,030
3 Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium J. Peter Donnelly et al. · Clinical Infectious Diseases Open access 8 Oct 2019 2,973
4 Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Oliver A. Cornely et al. · The Lancet Infectious Diseases Open access 4 Nov 2019 1,841
5 Real-time, portable genome sequencing for Ebola surveillance Joshua C Quick et al. · Nature Open access102 authors Feb 2016 1,600
6 Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study Jamie Lopez Bernal, Nick J Andrews, Charlotte Gower et al. · BMJ Open access 13 May 2021 1,398
7 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey et al. · The Lancet Open access766 authors 21 Feb 2021 1,213
8 Tackling the emerging threat of antifungal resistance to human health Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith G. Berman et al. · Nature Reviews Microbiology ReviewOpen access 29 Mar 2022 1,185
9 SARS-CoV-2 evolution during treatment of chronic infection Steven A. Kemp et al. · Nature Open access1,134 authors 5 Feb 2021 1,091
10 Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity Erik Volz et al. · Cell Open access581 authors 18 Nov 2020 1,086
11 Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study Melina Arnold et al. · The Lancet Oncology Open access 11 Sep 2019 1,083
12 Life course health consequences and associated annual costs of adverse childhood experiences across Europe and North America: a systematic review and meta-analysis Mark A Bellis, Karen E Hughes, Kat Ford et al. · The Lancet Public Health ReviewOpen access 3 Sep 2019 1,042
13 A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium William Checkley et al. · The Lancet Infectious Diseases Open access 30 Sep 2014 1,039
14 Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood Hywel C Williams et al. · Journal of Allergy and Clinical Immunology Open access 1999 999
15 Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Kevin W. Ng et al. · Science Open access 6 Nov 2020 994
16 Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance Philipp A. Koehler et al. · The Lancet Infectious Diseases Open access 16 Dec 2020 977
17 SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett et al. · Nature Microbiology Open access692 authors 7 Jul 2022 739
18 Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Dami A. Collier et al. · Nature Open access1,136 authors 11 Mar 2021 717
19 The SAIL databank: linking multiple health and social care datasets Ronan Anthony Lyons, Kerina Helen Jones, Gareth John et al. · BMC Medical Informatics and Decision Making Open access 16 Jan 2009 675
20 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R. W. Emary et al. · The Lancet Open access 30 Mar 2021 652
21 Cryptosporidium Pathogenicity and Virulence Maha Bouzid, Paul Raymond Hunter, Rachel M. Chalmers et al. · Clinical Microbiology Reviews Open access 2013 566
22 The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 Katrina Brown, Harriet Rumgay, Casey Dunlop et al. · British Journal of Cancer Open access 23 Mar 2018 565
23 Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data Angela B. Brueggemann et al. · The Lancet Digital Health Open access 24 May 2021 555
24 Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK Louis du Plessis et al. · Science Open access 8 Jan 2021 524
25 Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors Oct 2025 500
26 Preventing a covid-19 pandemic John P. Watkins · BMJ Open access 28 Feb 2020 492
27 Return on investment of public health interventions: a systematic review Rebecca Masters, Elspeth Anwar, Brendan Collins et al. · Journal of Epidemiology & Community Health ReviewOpen access 29 Mar 2017 487
28 Extreme water-related weather events and waterborne disease Kimberley Cann, Daniel Rhys Thomas, Roland L. Salmon et al. · Epidemiology and Infection Open access 9 Aug 2012 481
29 A National Strategy to Diagnose Coronavirus Disease 2019–Associated Invasive Fungal Disease in the Intensive Care Unit Philip Lewis White et al. · Clinical Infectious Diseases Open access 28 Aug 2020 455
30 The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries Martin Hoenigl, Danila Seidel, Agostinho Carvalho et al. · The Lancet Microbe Open access 25 Jan 2022 450
31 Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity Martin C. J. Maiden, Ana Belén Ibarz-Pavón, Rachel Urwin et al. · The Journal of Infectious Diseases Open access 13 Feb 2008 444
32 SARS-CoV-2 within-host diversity and transmission Katrina Lythgoe et al. · Science Open access 9 Mar 2021 442
33 Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19 Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham et al. · The Science of The Total Environment Open access 31 Jul 2020 435
34 Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis Ashley Bryce, Alastair D Hay, Isabel Lane et al. · BMJ ReviewOpen access 15 Mar 2016 425
35 Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas Michael H. Cullen, Neil Matthew Steven, Lucinda Jane Billingham et al. · New England Journal of Medicine Open access 7 Sep 2005 423
36 Mental health in UK Biobank – development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis Katrina A. S. Davis et al. · BJPsych Open Open access 6 Feb 2020 412
37 Measuring mortality and the burden of adult disease associated with adverse childhood experiences in England: a national survey Mark A Bellis, Karen E Hughes, Nicola Leckenby et al. · Journal of Public Health Open access 30 Aug 2014 407
38 Worldwide rates of diagnosis and effective treatment for cystic fibrosis Jonathan Guo, Anna Garratt, Andrew M. Hill · Journal of Cystic Fibrosis Open access 3 Feb 2022 392
39 Community transmission of monkeypox in the United Kingdom, April to May 2022 Roberto Vivancos et al. · Eurosurveillance Open access 2 Jun 2022 388
40 Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening Maria A. Loane et al. · European Journal of Human Genetics Open access 20 Jun 2012 377
41 Development of a framework for the co-production and prototyping of public health interventions Jemma L. Hawkins, Kim Madden, Adam Fletcher et al. · BMC Public Health Open access 4 Sep 2017 339
42 Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase Amit Goyal, Robert Gordon Newcombe, Alok Chhabra et al. · Breast Cancer Research and Treatment 15 Mar 2006 334
43 A comparison of gender-linked population cancer risks between alcohol and tobacco: how many cigarettes are there in a bottle of wine? Theresa Hydes, Robyn Burton, Hazel M. Inskip et al. · BMC Public Health Open access 27 Mar 2019 330
44 Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency Josep Vidal‐Alaball, Christopher Butler, Rebecca L. Cannings-John et al. · Cochrane Database of Systematic Reviews Open access 4 Jul 2005 328
45 Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study M McGivern et al. · Archives of Disease in Childhood Fetal & Neonatal 19 Nov 2014 317
46 Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results Edward T. M. Smyth, Gerry McIlvenny, J.E. Enstone et al. · Journal of Hospital Infection 12 Jun 2008 311
47 The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence Katy Turner, Sharon J. Hutchinson, Peter T. Vickerman et al. · Addiction 25 May 2011 304
48 Health and financial costs of adverse childhood experiences in 28 European countries: a systematic review and meta-analysis Karen E Hughes, Kat Ford, Mark A Bellis et al. · The Lancet Public Health ReviewOpen access 28 Oct 2021 302
49 C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations Christopher Butler, David Ch. Gillespie, Patrick T. White et al. · New England Journal of Medicine Open access 10 Jul 2019 287
50 Systematic review and meta‐analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer Ceri Beaton, Christopher P. Twine, Gethin Llewellyn Williams et al. · Colorectal Disease ReviewOpen access 20 Jan 2013 281

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.